Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand
暂无分享,去创建一个
Julie A. Campbell | R. Norman | W. Carroll | H. Butzkueven | C. Blizzard | A. Palmer | I. van der Mei | D. Mason | T. Kalincik | S. Claflin | S. Simpson-Yap | G. J. Henson | B. Taylor | G. Henson | I. A. van der Mei